Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT

INTRODUCTION: During early clinical testing of a new medication, it is critical to understand and characterise patient tolerability. However, in early clinical studies, it is difficult for patients to contribute directly to the sponsors’ understanding of a new compound. Patient reported opinions abo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hughes, Andrew, Landers, Donal, Arkenau, Hendrik-Tobias, Shah, Saj, Stephens, Richard, Mahal, Amrik, Simmons, Matthew, Lemech, Charlotte, Royle, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920852/
https://www.ncbi.nlm.nih.gov/pubmed/27167621
http://dx.doi.org/10.1007/s12325-016-0335-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920852/
https://www.ncbi.nlm.nih.gov/pubmed/27167621
http://dx.doi.org/10.1007/s12325-016-0335-4

Ejemplares similares